SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-052137
Filing Date
2024-05-02
Accepted
2024-05-02 16:15:32
Documents
59
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lbph-20240331.htm   iXBRL 10-Q 1925934
2 EX-3.2 lbph-ex3_2.htm EX-3.2 218698
3 EX-10.1 lbph-ex10_1.htm EX-10.1 105491
4 EX-31.1 lbph-ex31_1.htm EX-31.1 16762
5 EX-31.2 lbph-ex31_2.htm EX-31.2 16805
6 EX-32.1 lbph-ex32_1.htm EX-32.1 15581
  Complete submission text file 0000950170-24-052137.txt   8449346

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lbph-20240331.xsd EX-101.SCH 962214
63 EXTRACTED XBRL INSTANCE DOCUMENT lbph-20240331_htm.xml XML 1700522
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Filer) CIK: 0001832168 (see all company filings)

IRS No.: 845009619 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40192 | Film No.: 24908480
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)